|
T0
|
T1
|
T2
|
---|
CRP (mg/dl)
|
12.3
|
12
|
2.3
|
PCT (ng/ml)
|
3.2
|
3
|
1
|
EAA
|
0.71
|
0.6
|
0.5
|
FEVER (°C)
|
40
|
38
|
36.5
|
SVR (dynes second/cm5)
|
400
|
600
|
1200
|
CO
|
2.1
|
3.0
|
5.2
|
MAP
|
50
|
70
|
85
|
- T0: Before the beginning of IgM-enriched immunoglobulin preparation (Pentaglobin) and direct hemoperfusion therapy with polymyxin B immobilized fiber cartridges
- T1: 24 hours after the beginning of IgM-enriched immunoglobulin preparation (Pentaglobin) and direct hemoperfusion therapy with polymyxin B immobilized fiber cartridge
- T2: 72 hours after the beginning of IgM-enriched immunoglobulin preparation (Pentaglobin) and direct hemoperfusion therapy with polymyxin B immobilized fiber cartridge
- CO cardiac output, CRP C-reactive protein, EAA endotoxin activity assay, MAP mean arterial pressure, PCT procalcitonin, SVR systemic vascular resistance